A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Estazolam
Methoxy polyethylene glycol-epoetin beta
The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Pralatrexate.
Estazolam
Peginesatide
The risk or severity of Thrombosis can be increased when Pralatrexate is combined with Peginesatide.
Estazolam
Sipuleucel-T
The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Pralatrexate.
Estazolam
Roflumilast
Roflumilast may increase the immunosuppressive activities of Pralatrexate.
Estazolam
Difluocortolone
The risk or severity of adverse effects can be increased when Pralatrexate is combined with Difluocortolone.
Estazolam
Clobetasol
The risk or severity of adverse effects can be increased when Pralatrexate is combined with Clobetasol.
Estazolam
Fluocortolone
The risk or severity of adverse effects can be increased when Pralatrexate is combined with Fluocortolone.
Estazolam
Hydrocortisone butyrate
The risk or severity of adverse effects can be increased when Pralatrexate is combined with Hydrocortisone butyrate.
Estazolam
Bleselumab
The risk or severity of adverse effects can be increased when Pralatrexate is combined with Bleselumab.
Estazolam
Rozanolixizumab
The risk or severity of adverse effects can be increased when Pralatrexate is combined with Rozanolixizumab.
Estazolam
Risankizumab
The risk or severity of adverse effects can be increased when Pralatrexate is combined with Risankizumab.
Estazolam
Emapalumab
The risk or severity of adverse effects can be increased when Pralatrexate is combined with Emapalumab.
Estazolam
Hydrocortisone succinate
The risk or severity of adverse effects can be increased when Pralatrexate is combined with Hydrocortisone succinate.
Estazolam
Hydrocortisone acetate
The risk or severity of adverse effects can be increased when Pralatrexate is combined with Hydrocortisone acetate.
Estazolam
Mometasone furoate
The risk or severity of adverse effects can be increased when Pralatrexate is combined with Mometasone furoate.
Estazolam
Monomethyl fumarate
The risk or severity of adverse effects can be increased when Pralatrexate is combined with Monomethyl fumarate.
Estazolam
Tetrandrine
The risk or severity of adverse effects can be increased when Pralatrexate is combined with Tetrandrine.
Estazolam
Fluticasone
The risk or severity of adverse effects can be increased when Pralatrexate is combined with Fluticasone.
Estazolam
Fluclorolone
The risk or severity of adverse effects can be increased when Pralatrexate is combined with Fluclorolone.
Estazolam
Cloprednol
The risk or severity of adverse effects can be increased when Pralatrexate is combined with Cloprednol.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3